Stay updated with breaking news from Accoya. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Coya Therapeutics (NASDAQ:COYA – Get Free Report) is one of 974 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its peers? We will compare Coya Therapeutics to related companies based on the strength of its earnings, dividends, analyst recommendations, valuation, profitability, institutional ownership and risk. Volatility & Risk Coya Therapeutics […]
Coya Therapeutics (NASDAQ:COYA – Get Free Report) is one of 975 public companies in the “Pharmaceutical preparations” industry, but how does it contrast to its rivals? We will compare Coya Therapeutics to related businesses based on the strength of its profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Analyst Ratings This is a […]
Coya Therapeutics (NASDAQ:COYA – Get Free Report) and Spero Therapeutics (NASDAQ:SPRO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership. Volatility and Risk Coya Therapeutics has a […]
Coya Therapeutics, Inc. (NASDAQ:COYA – Get Free Report) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 31,700 shares, a growth of 41.5% from the November 30th total of 22,400 shares. Based on an average trading volume of 46,700 shares, the days-to-cover ratio […]
By Will Feuer Coya Therapeutics said it will sell about $26.5 million worth of stock in a private placement that includes participation from former U.S....